(FRLN) – Guidance
-
Freeline Therapeutics Holdings (FRLN) announces restructuring organization and pausing development of FLT190 to extend cash runway into Q2 2024
-
Freeline Therapeutics Holdings (FRLN) Announces 2022 Corporate Priorities and Guidance
Back to FRLN Stock Lookup